4.8 Article

ACK1/TNK2 Regulates Histone H4 Tyr88-phosphorylation and AR Gene Expression in Castration-Resistant Prostate Cancer

期刊

CANCER CELL
卷 31, 期 6, 页码 790-+

出版社

CELL PRESS
DOI: 10.1016/j.ccell.2017.05.003

关键词

-

资金

  1. NIH/NCI [5R01CA135328]
  2. Department of Defense [W81XWH-14-1-0002, W81XWH-14-1-0003, W81XWH-15-1-0312, W81XWH-12-1-0248, W81XWH-14-1-0251, W81XWH-15-1-0059]
  3. Bankhead-Coley [6BC08]
  4. Miles-for-Moffitt Award [09-33661-15-13]
  5. Core Facilities at Moffitt Cancer Center
  6. Cancer Center Support Grant [P30 CA076292]

向作者/读者索取更多资源

The androgen receptor (AR) is critical for the progression of prostate cancer to a castration-resistant (CRPC) state. AR antagonists are ineffective due to their inability to repress the expression of AR or its splice variant, AR-V7. Here, we report that the tyrosine kinase ACK1 (TNK2) phosphorylates histone H4 at tyrosine 88 up-stream of the AR transcription start site. The WDR5/MLL2 complex reads the H4-Y88-phosphorylation marks and deposits the transcriptionally activating H3K4-trimethyl marks promoting AR transcription. Reversal of the pY88-H4 epigenetic marks by the ACK1 inhibitor (R)-9bMS-sensitized naive and enzalutamide-resistant prostate cancer cells and reduced AR and AR-V7 levels to mitigate CRPC tumor growth. Thus, a feedforward ACK1/pY88-H4/WDR5/MLL2/AR epigenetic circuit drives CRPC and is necessary for maintenance of the malignant state.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据